Pharmacovigilance content often moves under a different set of pressures than other life sciences documentation. An individual safety case may require rapid processing and reporting, while a DSUR, PSUR, PBRER, or Risk Management Plan may evolve across multiple reporting cycles, markets, reviewers, and product milestones.
In both situations, accurate translation is only part of the requirement. Safety teams also need terminology to remain consistent, critical numbers and dates to be handled carefully, recurring language to stay aligned, follow-up information to connect with earlier content, and multilingual files to move through defined review and delivery processes.
Coordinated intake, translation, review, QA, and delivery for urgent and expedited safety content.
Product terminology, medical language, safety concepts, and approved translations can remain aligned across related cases and follow-up information.
Translation memories, terminology resources, references, and controlled updates support recurring reports as safety content evolves.
Defined workflow stages, qualified linguists, independent review, technology-supported QA, and controlled delivery create a repeatable multilingual process.
Drug-safety information develops continuously—from the first incoming case through expedited reporting, periodic analysis, risk management, post-market monitoring, and communication of new safety information. Sesen provides multilingual support across this broader lifecycle so global teams can manage individual documents without losing continuity between them.
Accurate multilingual safety reporting begins with the information entering the case. Sesen translates source safety content used to capture and process adverse events while preserving clinical meaning and terminology from the beginning of the workflow.
Support time-sensitive safety reporting without removing the linguistic and quality controls that protect critical meaning. Workflows can be structured around short reporting timelines while retaining specialized translation, review, and focused QA.
Maintain consistency across recurring global safety reports and reporting cycles. Translation memories, approved references, product terminology, and previous translations can help teams manage updates while keeping new content aligned with established language.
Keep multilingual signal and risk content precise as safety knowledge evolves. Terminology management helps maintain alignment among safety concepts, product terminology, supporting documents, and previously approved language.
Support ongoing multilingual safety surveillance throughout the commercial product lifecycle as new cases, follow-up information, analyses, product safety updates, and revised risk information emerge across global markets.
Deliver consistent safety messages to regulators, healthcare professionals, patients, investigators, affiliates, and global teams while maintaining alignment with established medical, product, and safety terminology.
Sesen provides specialized drug-safety translation across individual case reporting, periodic reporting, risk management, post-market surveillance, and safety communication.
Adverse event reports and supporting source information for global safety programs.
Time-sensitive SAE content requiring accurate medical terminology and careful handling of critical details.
ICSR content, narratives, follow-up information, and supporting case documentation.
Suspected unexpected serious adverse reaction content and associated safety communications.
Narrative and supporting information contained in CIOMS safety-reporting documentation.
Patient and case narratives with chronology, medical meaning, treatment information, and safety details preserved.
DSUR content supporting periodic safety reporting during clinical development.
PSUR content, supporting sections, tables, summaries, and updated safety information.
PBRER content across recurring reporting cycles, including safety and benefit-risk information.
Recurring safety reports and associated updates across development and commercial programs.
Structured safety summaries, line listings, tables, narrative, and supporting documentation.
RMP content related to safety concerns, pharmacovigilance activities, risk minimization, and evolving product risk information.
Materials designed to communicate or support implementation of product risk-minimization measures.
Signal-related documentation, assessments, summaries, and associated communication.
Ongoing multilingual support for safety documentation generated throughout commercial product use.
Operational documentation supporting collaboration among sponsors, partners, affiliates, CROs, and safety organizations.
Clear safety information intended for physicians and other healthcare professionals.
Safety notifications, updates, and supporting materials used within clinical research programs.
Audience-appropriate safety content intended to help patients understand important product or treatment information.
Safety-related communication with health authorities and other regulatory stakeholders.
Consistent communication across central safety teams, regional organizations, affiliates, partners, and vendors.
Not every pharmacovigilance translation project should be managed the same way. An urgent ICSR or SAE report has different workflow needs from a PBRER that is updated periodically over several years. Sesen supports both through processes designed around the timing, content, and continuity requirements of the safety program.
For AE, SAE, ICSR, SUSAR, follow-up reports, and urgent safety communications.
For DSUR, PSUR, PBRER, RMP, recurring narratives, and post-market updates.
Drug-safety terminology appears repeatedly across individual cases, narratives, aggregate reports, risk documentation, regulatory communication, and post-market updates. Sesen treats terminology as an ongoing program asset rather than a one-time translation decision.
High-stakes safety translation requires more than fluency in two languages. It requires the ability to understand medical meaning, preserve case detail, manage terminology, recognize critical data, and apply a repeatable quality process.
Projects are assigned to professional linguists selected for relevant medical, pharmaceutical, and life sciences expertise.
A second qualified linguist reviews translated content for accuracy, completeness, terminology, language quality, and internal consistency.
Available glossaries, translation memories, product terminology, previous translations, references, and client instructions are incorporated into the workflow.
Final linguistic and file-level QA helps confirm that intended content has been translated, reviewed, and prepared in the required deliverable format.
Technology can strengthen quality control by helping identify potential inconsistencies and production risks across large or time-sensitive multilingual files. These tools support professional review rather than replace it.
Qualified linguists remain responsible for interpreting context, evaluating clinical meaning, resolving linguistic ambiguity, and determining final translation quality.
Sesen combines specialized human expertise, terminology resources, translation technology, and quality controls within a repeatable production workflow.
Review files, languages, deadlines, safety priorities, references, and project requirements.
Prepare terminology, translation memories, product references, prior translations, and client instructions.
Assign qualified life sciences linguists to translate the safety content.
Perform independent linguistic review for meaning, terminology, consistency, and completeness.
Apply targeted human and technology-supported checks to critical text, data, formatting, and file integrity.
Prepare final files and maintain relevant translation assets for future cases and lifecycle updates.
Sesen works with life sciences organizations managing safety information across clinical development, regulatory activity, commercialization, and ongoing product surveillance.
Multilingual support for individual markets, multicountry clinical programs, central and regional safety teams, affiliates, CRO-managed programs, commercial portfolios, and recurring global reporting cycles.
Support global drug-safety operations across individual cases, recurring reports, risk documentation, post-market activity, and safety communications.
Scale multilingual pharmacovigilance support as products progress from clinical development toward registration, commercialization, and expanded markets.
Provide dependable multilingual capacity across sponsor programs, safety documentation, case-related content, and recurring reporting requirements.
Connect safety translation with adjacent regulatory, clinical, labeling, and medical communication workflows while maintaining consistent terminology.
Pharmacovigilance content rarely arrives as one clean document. A safety program may include Word narratives, Excel line listings, PDFs, structured exports, forms, tables, tracked changes, reference materials, and files produced by different teams or systems.
Sesen can coordinate translation, linguistic review, file preparation, formatting, and final QA across these inputs and prepare multilingual deliverables in the required project format.
Explore focused Sesen services for specific drug-safety documents and workflows.
Adverse event reports, narratives, supporting source documents, and follow-up content.
SAE translation for time-sensitive clinical and post-market safety workflows.
Individual Case Safety Reports, case narratives, supporting content, and follow-up information.
SUSAR reports, notifications, and supporting communication for global clinical safety workflows.
Development Safety Update Reports and supporting aggregate safety documentation.
Recurring periodic safety and benefit-risk reports, updated sections, tables, and summaries.
RMPs and associated risk, pharmacovigilance, and risk-minimization content.
Patient and case narratives with close attention to chronology, medical meaning, and established safety terminology.
Specialized safety-content expertise, controlled linguistic assets, human-led quality, and scalable global delivery support both individual projects and ongoing pharmacovigilance programs.
Medical and pharmaceutical linguists selected for safety cases, narratives, periodic reports, risk documentation, and related safety content.
Translation memories, terminology resources, approved references, and recurring linguistic assets connect projects into a controlled multilingual program.
Professional linguists and independent reviewers remain responsible for meaning and language quality, supported by technology that strengthens consistency and QA.
From one urgent safety case to recurring reports across multiple languages and markets, workflows can scale with program cadence and complexity.
Sesen combines specialized life sciences expertise with certified quality-management and translation processes. For pharmacovigilance programs, these practices support qualified linguistic resources, documented review, terminology control, confidentiality, and repeatable multilingual delivery.
Answers to common questions about drug-safety translation workflows, terminology, quality control, global programs, and structured content.
Whether you are managing an urgent safety case, a recurring aggregate report, an expanding product portfolio, or a global pharmacovigilance program, Sesen can help keep multilingual safety information accurate, consistent, and controlled.
